FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis
Top Cited Papers
Open Access
- 1 March 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 19 (3), 429-435
- https://doi.org/10.1359/jbmr.0301264
Abstract
We analyzed the effects of an FGF‐23 injection in vivo. FGF‐23 caused a reduction in serum 1,25‐dihydroxyvitamin D by altering the expressions of key enzymes for the vitamin D metabolism followed by hypophosphatemia. This study indicates that FGF‐23 is a potent regulator of the vitamin D and phosphate metabolism. Introduction: The pathophysiological contribution of FGF‐23 in hypophosphatemic diseases was supported by animal studies in which the long‐term administration of recombinant fibroblast growth factor‐23 reproduced hypophosphatemic rickets with a low serum 1,25‐dihydroxyvitamin D [1,25(OH)2D] level. However, there is no clear understanding of how FGF‐23 causes these changes. Materials and Methods: To elucidate the molecular mechanisms of the FGF‐23 function, we investigated the short‐term effects of a single administration of recombinant FGF‐23 in normal and parathyroidectmized animals. Results: An injection of recombinant FGF‐23 caused a reduction in serum phosphate and 1,25(OH)2D levels. A decrease in serum phosphate was first observed 9 h after the injection and was accompanied with a reduction in renal mRNA and protein levels for the type IIa sodium‐phosphate cotransporter (NaPi‐2a). There was no increase in the parathyroid hormone (PTH) level throughout the experiment, and hypophosphatemia was reproduced by FGF‐23 in parathyroidectomized rats. Before this hypophosphatemic effect, the serum 1,25(OH)2D level had already descended at 3 h and reached the nadir 9 h after the administration. FGF‐23 reduced renal mRNA for 25‐hydroxyvitamin D‐1α‐hydroxylase and increased that for 25‐hydroxyvitamin D‐24‐hydroxylase starting at 1 h. In addition, an injection of calcitriol into normal mice increased the serum FGF‐23 level within 4 h. Conclusions: FGF‐23 regulates NaPi‐2a independently of PTH and the serum 1,25(OH)2D level by controlling renal expressions of key enzymes of the vitamin D metabolism. In conclusion, FGF‐23 is a potent regulator of phosphate and vitamin D homeostasis.Keywords
This publication has 22 references indexed in Scilit:
- Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked HypophosphatemiaNew England Journal of Medicine, 2003
- The Autosomal Dominant Hypophosphatemic Rickets R176Q Mutation in Fibroblast Growth Factor 23 Resists Proteolytic Cleavage and Enhances in Vivo Biological PotencyJournal of Biological Chemistry, 2003
- Increased Circulatory Level of Biologically Active Full-Length FGF-23 in Patients with Hypophosphatemic Rickets/OsteomalaciaJournal of Clinical Endocrinology & Metabolism, 2002
- Fibroblast Growth Factor (FGF)-23 Inhibits Renal Phosphate Reabsorption by Activation of the Mitogen-activated Protein Kinase PathwayJournal of Biological Chemistry, 2002
- Growth-related Renal Type II Na/Pi CotransporterPublished by Elsevier ,2002
- Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23Kidney International, 2001
- Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalaciaProceedings of the National Academy of Sciences, 2001
- Renal brush border membrane Na/Pi-cotransport: Molecular aspects in PTH-dependent and dietary regulationKidney International, 1996
- Identification of a Vitamin D Receptor Homodimer-Type Response Element in the Rat Calcitriol 24-Hydroxylase Gene PromoterBiochemical and Biophysical Research Communications, 1994
- A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of d-glucose and choline transport systemsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1978